It has been observed that constitutive NF-κB activation also occurs in long-term inflammation (i.e., in inflammatory bowel diseases (IBDs) patients), which induces the expression of cytokines, such as tumor necrosis factor (TNF)-α, interleukin (IL)-6, and other chemokines, supporting the inflammation-related tissue damage. This evidence concerns the gene TNF and inflammatory bowel disease.